协作照护对精神-躯体共病患者长期临床效果与成本效益的集群随机试验
该集群随机试验比较协作照护与常规照护对抑郁共病糖尿病和/或冠心病患者的24个月效果与成本效益。191例分配至协作照护、196例至常规照护;
要点
- 协作照护在24个月时较常规照护降低抑郁症状评分(SCL-D13平均低0.27)。
- 长期看协作照护可能在国际可接受的支付阈值内具有成本效益。
核心结论
- 长期看协作照护可减轻精神-躯体共病患者的抑郁并可能具有成本效益。
研究设计与样本
- 集群随机试验比较协作照护(整合躯体与精神卫生服务)与常规照护,用于抑郁共病糖尿病和/或冠心病患者。
- 协作照护组191例,常规照护组196例,随访24个月。
- 抑郁症状采用症状 checklist-抑郁量表(SCL-D13)测量,经济评价从英国国家卫生服务体系视角进行。
主要发现
- 24个月时协作照护组平均SCL-D13评分较常规照护组低0.27(95% CI,-0.48至-0.06)。
- 协作照护组获得0.14个质量调整生命年(QALYs)(95% CI,0.06至0.21)。
临床怎么用
- 对抑郁共病糖尿病和/或冠心病的患者,可考虑整合躯体与精神卫生服务的协作照护模式以改善长期抑郁结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Collaborative care can support the treatment of depression in people with long-term conditions, but long-term benefits and costs are unknown.AimsTo explore the long-term (24-month) effectiveness and cost-effectiveness of collaborative care in people with mental-physical multimorbidity. METHOD: A cluster randomised trial compared collaborative care (integrated physical and mental healthcare) with usual care for depression alongside diabetes and/or coronary heart disease. Depression symptoms were measured by the symptom checklist-depression scale (SCL-D13). The economic evaluation was from the perspective of the English National Health Service. RESULTS: 191 participants were allocated to collaborative care and 196 to usual care. At 24 months, the mean SCL-D13 score was 0.27 (95% CI, -0.48 to -0.06) lower in the collaborative care group alongside a gain of 0.14 (95% CI, 0.06-0.21) quality-adjusted life-years (QALYs). The cost per QALY gained was £13 069. CONCLUSIONS: In the long term, collaborative care reduces depression and is potentially cost-effective at internationally accepted willingness-to-pay thresholds.Declaration of interestNone.
引用
- Camacho EM, Davies LM, Hann M, et al. Long-term clinical and cost-effectiveness of collaborative care (versus usual care) for people with mental-physical multimorbidity: cluster-randomised trial. Br J Psychiatry. 2018. PMID: 29761751. doi:10.1192/bjp.2018.70
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。